These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 26477687)

  • 1. Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP/thrombotic microangiopathy registry.
    Blombery P; Kivivali L; Pepperell D; McQuilten Z; Engelbrecht S; Polizzotto MN; Phillips LE; Wood E; Cohney S;
    Intern Med J; 2016 Jan; 46(1):71-9. PubMed ID: 26477687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and management of acquired thrombotic thrombocytopenic purpura in southeast China: a single center experience of 60 cases.
    Zhou X; Ye X; Ren Y; Mei C; Ma L; Huang J; Xu W; Wei J; Ye L; Mai W; Qian W; Meng H; Jin J; Tong H
    Front Med; 2016 Dec; 10(4):430-436. PubMed ID: 27878664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
    Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
    Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
    Shibagaki Y; Fujita T
    Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lombardy diagnostic and therapeutic network of thrombotic microangiopathy.
    Mancini I; Agosti P; Boscarino M; Ferrari B; Artoni A; Palla R; Spreafico M; Crovetti G; Volpato E; Rossini S; Novelli C; Gattillo S; Barcella L; Salmoiraghi M; Falanga A; Peyvandi F;
    Orphanet J Rare Dis; 2022 Jun; 17(1):246. PubMed ID: 35739601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradigm shift of childhood thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency.
    Yagi H; Matsumoto M; Fujimura Y
    Presse Med; 2012 Mar; 41(3 Pt 2):e137-55. PubMed ID: 22264931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan.
    Matsumoto M; Fujimura Y; Wada H; Kokame K; Miyakawa Y; Ueda Y; Higasa S; Moriki T; Yagi H; Miyata T; Murata M;
    Int J Hematol; 2017 Jul; 106(1):3-15. PubMed ID: 28550351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
    Soucemarianadin M; Benhamou Y; Delmas Y; Pichereau C; Maury E; Pène F; Halimi JM; Presne C; Thouret JM; Veyradier A; Coppo P
    Eur J Haematol; 2016 Aug; 97(2):183-91. PubMed ID: 26608617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of thrombotic thrombocytopenic purpura in two French centers: A series of 27 patients].
    Deroux A; Sirodot M; Daguindau N; Barro C; Coppo P; Bouillet L
    Rev Med Interne; 2016 Jan; 37(1):13-8. PubMed ID: 26065327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy.
    Joly BS; Stepanian A; Leblanc T; Hajage D; Chambost H; Harambat J; Fouyssac F; Guigonis V; Leverger G; Ulinski T; Kwon T; Loirat C; Coppo P; Veyradier A;
    Lancet Haematol; 2016 Nov; 3(11):e537-e546. PubMed ID: 27720178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab.
    Clark WF; Rock G; Barth D; Arnold DM; Webert KE; Yenson PR; Kelton JG; Li L; Foley SR;
    Br J Haematol; 2015 Jul; 170(2):208-17. PubMed ID: 25855259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Lupus Erythematosus Presenting as Refractory Thrombotic Thrombocytopenic Purpura: A Diagnostic and Management Challenge. A Case Report and Concise Review of the Literature.
    Abu-Hishmeh M; Sattar A; Zarlasht F; Ramadan M; Abdel-Rahman A; Hinson S; Hwang C
    Am J Case Rep; 2016 Oct; 17():782-787. PubMed ID: 27777394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical presentations of thrombotic thrombocytopenic purpura: a diagnostic role for ADAMTS13.
    Kalish Y; Rottenstreich A; Rund D; Hochberg-Klein S
    J Thromb Thrombolysis; 2016 Aug; 42(2):155-60. PubMed ID: 26867546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
    Intern Med J; 2018 Jun; 48(6):624-636. PubMed ID: 29582550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired, noncongenital thrombotic thrombocytopenic purpura in children and adolescents: clinical management and the use of ADAMTS 13 assays.
    McDonald V; Liesner R; Grainger J; Gattens M; Machin SJ; Scully M
    Blood Coagul Fibrinolysis; 2010 Apr; 21(3):245-50. PubMed ID: 20083997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced sensitivity of PLASMIC and French scores for the diagnosis of thrombotic thrombocytopenic purpura in older individuals.
    Liu A; Dhaliwal N; Upreti H; Kasmani J; Dane K; Moliterno A; Braunstein E; Brodsky R; Chaturvedi S
    Transfusion; 2021 Jan; 61(1):266-273. PubMed ID: 33179792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New developments in treatment modalities of thrombotic thrombocytopenic purpura].
    Matsumoto M
    Rinsho Ketsueki; 2017; 58(10):2081-2086. PubMed ID: 28978852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune thrombotic thrombocytopenic purpura in older patients: Results from the Spanish TTP Registry (REPTT).
    Gómez-Seguí I; Francés Aracil E; Mingot-Castellano ME; Vara Pampliega M; Goterris Viciedo R; García Candel F; Pascual Izquierdo C; Del Río Garma J; Guerra Domínguez L; Vicuña Andrés I; Garcia-Arroba Peinado J; Zalba Marcos S; Vidan Estévez JM; González Arias E; Campuzano Saavedra V; García Gala JM; Ortega Sanchez S; Martínez Nieto J; Pardo Gambarte L; Solé Rodríguez M; Fernández-Docampo M; Avila Idrovo LF; Hernández L; Cid J; de la Rubia Comos J;
    Br J Haematol; 2023 Dec; 203(5):860-871. PubMed ID: 37723363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indicators Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies in a Canadian Apheresis Referral Center.
    Martin SD; McGinnis E; Smith TW
    Am J Clin Pathol; 2021 Nov; 156(6):1103-1112. PubMed ID: 34160013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.